Jillian R Tate

Summary

Country: Australia

Publications

  1. doi The determination of the 99th centile level for troponin assays in an Australian reference population
    Jillian R Tate
    Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston, QLD 4029, Australia
    Ann Clin Biochem 45:275-88. 2008
  2. doi Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand
    Jillian Tate
    Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston Road, Brisbane, Queensland 4029, Australia
    Ann Clin Biochem 49:242-56. 2012
  3. pmc Interferences in immunoassay
    Jill Tate
    Department of Chemical Pathology, Queensland Health Pathology Service, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
    Clin Biochem Rev 25:105-20. 2004
  4. pmc Quantitative serum free light chain assay--analytical issues
    Jill Tate
    Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women s Hospital, Brisbane, Queensland, Australia
    Clin Biochem Rev 30:131-40. 2009
  5. doi Harmonization of laboratory testing - Current achievements and future strategies
    Jillian R Tate
    Pathology Queensland, Department of Chemical Pathology, Royal Brisbane and Women s Hospital, Brisbane, QLD, Australia Electronic address
    Clin Chim Acta 432:4-7. 2014
  6. ncbi Practical considerations for the measurement of free light chains in serum
    Jillian R Tate
    Chemical Pathology Department, Queensland Health Pathology Service, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia
    Clin Chem 49:1252-7. 2003
  7. doi Standardisation of cardiac troponin I measurement: past and present
    Jillian R Tate
    Pathology Queensland, Department of Chemical Pathology, Royal Brisbane and Women s Hospital, Herston, QLD, Australia
    Pathology 42:402-8. 2010
  8. ncbi The harmonization of cardiac troponin I measurement is independent of sample time collection but is dependent on the source of calibrator
    Jillian R Tate
    Department of Chemical Pathology, Queensland Health Pathology Service, Princess Alexandria Hospital, Woolloongabba, Queensland, Australia
    Clin Chim Acta 324:13-23. 2002
  9. doi Troponin revisited 2008: assay performance
    Jillian R Tate
    Department of Chemical Pathology, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston, QLD, Australia
    Clin Chem Lab Med 46:1489-500. 2008
  10. ncbi Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases
    Jillian R Tate
    Chemical Pathology Department, Queensland Health Pathology Service, Royal Brisbane and Princess Alexandra Hospitals, Brisbane, Australia
    Clin Chim Acta 376:30-6. 2007

Detail Information

Publications13

  1. doi The determination of the 99th centile level for troponin assays in an Australian reference population
    Jillian R Tate
    Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston, QLD 4029, Australia
    Ann Clin Biochem 45:275-88. 2008
    ..The 99th centile level for eight troponin assays was determined in an apparently cardio-healthy Australian reference population...
  2. doi Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand
    Jillian Tate
    Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston Road, Brisbane, Queensland 4029, Australia
    Ann Clin Biochem 49:242-56. 2012
    ..The Australasian Association of Clinical Biochemists recognized a need to adopt a standardized approach to reporting SPEP and UPEP by clinical laboratories...
  3. pmc Interferences in immunoassay
    Jill Tate
    Department of Chemical Pathology, Queensland Health Pathology Service, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
    Clin Biochem Rev 25:105-20. 2004
    ..The establishment of on-going laboratory-physician contact is essential to the continuing awareness of wrong patient results due to interference...
  4. pmc Quantitative serum free light chain assay--analytical issues
    Jill Tate
    Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women s Hospital, Brisbane, Queensland, Australia
    Clin Biochem Rev 30:131-40. 2009
    ..These issues, if not adequately appreciated, have the potential to mislead clinical diagnosis and assessment of response to therapy...
  5. doi Harmonization of laboratory testing - Current achievements and future strategies
    Jillian R Tate
    Pathology Queensland, Department of Chemical Pathology, Royal Brisbane and Women s Hospital, Brisbane, QLD, Australia Electronic address
    Clin Chim Acta 432:4-7. 2014
    ....
  6. ncbi Practical considerations for the measurement of free light chains in serum
    Jillian R Tate
    Chemical Pathology Department, Queensland Health Pathology Service, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia
    Clin Chem 49:1252-7. 2003
    ..We describe experience with and some potential pitfalls of the assay...
  7. doi Standardisation of cardiac troponin I measurement: past and present
    Jillian R Tate
    Pathology Queensland, Department of Chemical Pathology, Royal Brisbane and Women s Hospital, Herston, QLD, Australia
    Pathology 42:402-8. 2010
    ....
  8. ncbi The harmonization of cardiac troponin I measurement is independent of sample time collection but is dependent on the source of calibrator
    Jillian R Tate
    Department of Chemical Pathology, Queensland Health Pathology Service, Princess Alexandria Hospital, Woolloongabba, Queensland, Australia
    Clin Chim Acta 324:13-23. 2002
    ..We concluded that due to the heterogeneity of clinical samples, use of a pooled human serum material might better serve as a secondary reference reagent for cTnI measurement...
  9. doi Troponin revisited 2008: assay performance
    Jillian R Tate
    Department of Chemical Pathology, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston, QLD, Australia
    Clin Chem Lab Med 46:1489-500. 2008
    ..Close collaboration between the laboratory and local clinicians is required to ensure adequate clinical validation of more sensitive cTn assays...
  10. ncbi Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases
    Jillian R Tate
    Chemical Pathology Department, Queensland Health Pathology Service, Royal Brisbane and Princess Alexandra Hospitals, Brisbane, Australia
    Clin Chim Acta 376:30-6. 2007
    ..We report on our experience with the assay during monitoring of light-chain myeloma (LCMM) and AL amyloidosis (AL)...
  11. ncbi Identification of an apolipoprotein(e) variant associated with type III hyperlipoproteinaemia in an indigenous Australian
    J R Tate
    Department of Chemical Pathology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Ann Clin Biochem 38:46-53. 2001
    ....
  12. ncbi Reporting of cardiac troponin concentrations
    Jillian R Tate
    Clin Chem 48:2077-80; author reply 2080-2. 2002
  13. ncbi First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B
    Francesco Dati
    IVD Consulting, Marburg, Germany
    Clin Chem Lab Med 42:670-6. 2004
    ....